Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study

Avallone G;Bombelli A;Gargiulo L;Foti C;Trave I;Rossi M;Magnaterra E;Pigliacelli F;Malagoli P;Giacalone S;Portarapillo A;Patruno C;Schettini N;Bonzano L;Pezzolo E;Chello C;Gori N;Brunasso G;Veronese F;Ortoncelli M;Tolino E;Azzolini A;Bellinato F;Hansel K;Di Brizzi EV;Gurioli C;Esposito M;Giuffrida R;Barei F;Calzari P;Burroni AG;Gola M;Mariano M;Fargnoli MC;Napolitano M;Grieco T;Peris K;Savoia P;Ribero S;Girolomoni G;Stingeni L;Balato A;Costanzo A;Marzano AV;Narcisi A;Ferrucci SM

2025-01-01